Literature DB >> 28360341

Inorganic Nitrates: Qi for Heart Failure With Preserved Ejection Fraction?

Kavita Sharma1, David A Kass2.   

Abstract

Entities:  

Keywords:  Editorials; heart failure; human; nitrate; nitric oxide; pharmacology

Mesh：

Substances：

Year:  2017        PMID： 28360341      PMCID： PMC5398899          DOI： 10.1161/CIRCRESAHA.117.310699

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  14 in total

Review 1.  Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies.

Authors:  Kavita Sharma; David A Kass
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

2.  Pharmacokinetics and Pharmacodynamics of Inorganic Nitrate in Heart Failure With Preserved Ejection Fraction.

Authors:  Payman Zamani; Victor Tan; Haideliza Soto-Calderon; Melissa Beraun; Jeffrey A Brandimarto; Lien Trieu; Swapna Varakantam; Paschalis-Thomas Doulias; Raymond R Townsend; Jesse Chittams; Kenneth B Margulies; Thomas P Cappola; David C Poole; Harry Ischiropoulos; Julio A Chirinos
Journal:  Circ Res       Date:  2016-12-07       Impact factor: 17.367

3.  Benefit of glyceryl trinitrate on arterial stiffness is directly due to effects on peripheral arteries.

Authors:  A L Pauca; N D Kon; M F O'Rourke
Journal:  Heart       Date:  2005-03-10       Impact factor: 5.994

4.  Vasodilation in black Americans: attenuated nitric oxide-mediated responses.

Authors:  C M Stein; C C Lang; R Nelson; M Brown; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1997-10       Impact factor: 6.875

5.  Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction.

Authors:  Barry A Borlaug; Vojtech Melenovsky; Stuart D Russell; Kristy Kessler; Karel Pacak; Lewis C Becker; David A Kass
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

6.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Authors:  Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

Review 7.  The Nitrate-Nitrite-NO Pathway and Its Implications for Heart Failure and Preserved Ejection Fraction.

Authors:  Julio A Chirinos; Payman Zamani
Journal:  Curr Heart Fail Rep       Date:  2016-02

Review 8.  Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress.

Authors:  Andreas Daiber; Thomas Münzel
Journal:  Antioxid Redox Signal       Date:  2015-09-24       Impact factor: 8.401

9.  Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction.

Authors:  Barry A Borlaug; Katlyn E Koepp; Vojtech Melenovsky
Journal:  J Am Coll Cardiol       Date:  2015-10-13       Impact factor: 24.094

10.  Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study.

Authors:  Burkert Pieske; Aldo P Maggioni; Carolyn S P Lam; Elisabeth Pieske-Kraigher; Gerasimos Filippatos; Javed Butler; Piotr Ponikowski; Sanjiv J Shah; Scott D Solomon; Andrea-Viviana Scalise; Katharina Mueller; Lothar Roessig; Mihai Gheorghiade
Journal:  Eur Heart J       Date:  2017-04-14       Impact factor: 29.983
View more
  2 in total

1.  Edward F. Adolph Distinguished Lecture. Contemporary model of muscle microcirculation: gateway to function and dysfunction.

Authors:  David C Poole
Journal:  J Appl Physiol (1985)       Date:  2019-05-16

Review 2.  The role of vascular function on exercise capacity in health and disease.

Authors:  David C Poole; Brad J Behnke; Timothy I Musch
Journal:  J Physiol       Date:  2020-03-03       Impact factor: 5.182
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.